CFDP1 is a neuroblastoma susceptibility gene that regulates transcription factors of the noradrenergic cell identity

Summary: Pleiotropic genetic factors (e.g., DNA polymorphisms) may be involved in the initiation of neuroblastoma (NB) and coronary artery disease (CAD) given their common origin from defects in neural crest development. To discover novel NB susceptibility genes, we conducted a three-stage survey in...

Full description

Bibliographic Details
Main Authors: Daniela Formicola, Vito Alessandro Lasorsa, Sueva Cantalupo, Alessandro Testori, Antonella Cardinale, Marianna Avitabile, Sharon Diskin, Achille Iolascon, Mario Capasso
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:HGG Advances
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666247722000756
_version_ 1797984147870842880
author Daniela Formicola
Vito Alessandro Lasorsa
Sueva Cantalupo
Alessandro Testori
Antonella Cardinale
Marianna Avitabile
Sharon Diskin
Achille Iolascon
Mario Capasso
author_facet Daniela Formicola
Vito Alessandro Lasorsa
Sueva Cantalupo
Alessandro Testori
Antonella Cardinale
Marianna Avitabile
Sharon Diskin
Achille Iolascon
Mario Capasso
author_sort Daniela Formicola
collection DOAJ
description Summary: Pleiotropic genetic factors (e.g., DNA polymorphisms) may be involved in the initiation of neuroblastoma (NB) and coronary artery disease (CAD) given their common origin from defects in neural crest development. To discover novel NB susceptibility genes, we conducted a three-stage survey including a meta-analysis of NB and CAD genome-wide association data, prioritization of NB causal variants, and validation in an independent cohort of affected individuals–control subjects. The lead SNP, rs13337397 at the 16q23.1 locus, associated with both diseases in the meta-analysis and with NB in the validation study. All the SNPs in linkage disequilibrium with rs13337397 were annotated using the H3K27ac epigenetic marker of neural crest cells (NCC) and NB cell lines. Indeed, we identified the functional SNP rs13337017, mapping within an enhancer of NCCs and NB cell lines and showing long-range interactions with CFDP1 by Hi-C analysis. Luciferase assays indicated that the risk allele of rs13337017 increased CFDP1 expression in NB cell lines. Of note, CFDP1 high expression associated with unfavorable prognostic markers in an analysis including 498 NB transcriptomes. Moreover, depletion of CFDP1 markedly decreased viability and migration and increased apoptotic rates in NB cell lines. Finally, transcriptome and qPCR analyses revealed that the depletion of CFDP1 may affect noradrenergic neuron differentiation by downregulating master regulators of sympathetic noradrenergic identity, including PHOX2B, HAND2, and GATA3. Our data strongly suggest that CFDP1 acts as oncogene in NB. In addition, we provide evidence that genetic predisposition to NB can be mediated by the alteration of noradrenergic lineage-specific gene expression.
first_indexed 2024-04-11T06:58:01Z
format Article
id doaj.art-9a7c30faddfd4f2185e66863ef345267
institution Directory Open Access Journal
issn 2666-2477
language English
last_indexed 2024-04-11T06:58:01Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series HGG Advances
spelling doaj.art-9a7c30faddfd4f2185e66863ef3452672022-12-22T04:38:57ZengElsevierHGG Advances2666-24772023-01-0141100158CFDP1 is a neuroblastoma susceptibility gene that regulates transcription factors of the noradrenergic cell identityDaniela Formicola0Vito Alessandro Lasorsa1Sueva Cantalupo2Alessandro Testori3Antonella Cardinale4Marianna Avitabile5Sharon Diskin6Achille Iolascon7Mario Capasso8Dipartimento di Neurobiologia e Medicina Molecolare, IRCSS Fondazione Stella Maris, 56128 Pisa, Italy; CEINGE Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore 486, 80145 Napoli, Italy; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via Pansini, 5, 80131 Napoli, ItalyCEINGE Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore 486, 80145 Napoli, Italy; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via Pansini, 5, 80131 Napoli, ItalyCEINGE Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore 486, 80145 Napoli, Italy; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via Pansini, 5, 80131 Napoli, ItalyCEINGE Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore 486, 80145 Napoli, Italy; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via Pansini, 5, 80131 Napoli, Italy; Division of Genetics, Children’s Hospital of Philadelphia, Philadelphia, PA, USACEINGE Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore 486, 80145 Napoli, Italy; Department of Pediatric Hematology and Oncology, Bambino Gesù Children’s Hospital, IRCCS, Roma, ItalyCEINGE Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore 486, 80145 Napoli, Italy; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via Pansini, 5, 80131 Napoli, ItalyDivision of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USACEINGE Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore 486, 80145 Napoli, Italy; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via Pansini, 5, 80131 Napoli, ItalyCEINGE Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore 486, 80145 Napoli, Italy; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Via Pansini, 5, 80131 Napoli, Italy; Corresponding authorSummary: Pleiotropic genetic factors (e.g., DNA polymorphisms) may be involved in the initiation of neuroblastoma (NB) and coronary artery disease (CAD) given their common origin from defects in neural crest development. To discover novel NB susceptibility genes, we conducted a three-stage survey including a meta-analysis of NB and CAD genome-wide association data, prioritization of NB causal variants, and validation in an independent cohort of affected individuals–control subjects. The lead SNP, rs13337397 at the 16q23.1 locus, associated with both diseases in the meta-analysis and with NB in the validation study. All the SNPs in linkage disequilibrium with rs13337397 were annotated using the H3K27ac epigenetic marker of neural crest cells (NCC) and NB cell lines. Indeed, we identified the functional SNP rs13337017, mapping within an enhancer of NCCs and NB cell lines and showing long-range interactions with CFDP1 by Hi-C analysis. Luciferase assays indicated that the risk allele of rs13337017 increased CFDP1 expression in NB cell lines. Of note, CFDP1 high expression associated with unfavorable prognostic markers in an analysis including 498 NB transcriptomes. Moreover, depletion of CFDP1 markedly decreased viability and migration and increased apoptotic rates in NB cell lines. Finally, transcriptome and qPCR analyses revealed that the depletion of CFDP1 may affect noradrenergic neuron differentiation by downregulating master regulators of sympathetic noradrenergic identity, including PHOX2B, HAND2, and GATA3. Our data strongly suggest that CFDP1 acts as oncogene in NB. In addition, we provide evidence that genetic predisposition to NB can be mediated by the alteration of noradrenergic lineage-specific gene expression.http://www.sciencedirect.com/science/article/pii/S2666247722000756GWASSNPneuroblastomaneural crest cellscoronary artery diseasepleiotropic variants
spellingShingle Daniela Formicola
Vito Alessandro Lasorsa
Sueva Cantalupo
Alessandro Testori
Antonella Cardinale
Marianna Avitabile
Sharon Diskin
Achille Iolascon
Mario Capasso
CFDP1 is a neuroblastoma susceptibility gene that regulates transcription factors of the noradrenergic cell identity
HGG Advances
GWAS
SNP
neuroblastoma
neural crest cells
coronary artery disease
pleiotropic variants
title CFDP1 is a neuroblastoma susceptibility gene that regulates transcription factors of the noradrenergic cell identity
title_full CFDP1 is a neuroblastoma susceptibility gene that regulates transcription factors of the noradrenergic cell identity
title_fullStr CFDP1 is a neuroblastoma susceptibility gene that regulates transcription factors of the noradrenergic cell identity
title_full_unstemmed CFDP1 is a neuroblastoma susceptibility gene that regulates transcription factors of the noradrenergic cell identity
title_short CFDP1 is a neuroblastoma susceptibility gene that regulates transcription factors of the noradrenergic cell identity
title_sort cfdp1 is a neuroblastoma susceptibility gene that regulates transcription factors of the noradrenergic cell identity
topic GWAS
SNP
neuroblastoma
neural crest cells
coronary artery disease
pleiotropic variants
url http://www.sciencedirect.com/science/article/pii/S2666247722000756
work_keys_str_mv AT danielaformicola cfdp1isaneuroblastomasusceptibilitygenethatregulatestranscriptionfactorsofthenoradrenergiccellidentity
AT vitoalessandrolasorsa cfdp1isaneuroblastomasusceptibilitygenethatregulatestranscriptionfactorsofthenoradrenergiccellidentity
AT suevacantalupo cfdp1isaneuroblastomasusceptibilitygenethatregulatestranscriptionfactorsofthenoradrenergiccellidentity
AT alessandrotestori cfdp1isaneuroblastomasusceptibilitygenethatregulatestranscriptionfactorsofthenoradrenergiccellidentity
AT antonellacardinale cfdp1isaneuroblastomasusceptibilitygenethatregulatestranscriptionfactorsofthenoradrenergiccellidentity
AT mariannaavitabile cfdp1isaneuroblastomasusceptibilitygenethatregulatestranscriptionfactorsofthenoradrenergiccellidentity
AT sharondiskin cfdp1isaneuroblastomasusceptibilitygenethatregulatestranscriptionfactorsofthenoradrenergiccellidentity
AT achilleiolascon cfdp1isaneuroblastomasusceptibilitygenethatregulatestranscriptionfactorsofthenoradrenergiccellidentity
AT mariocapasso cfdp1isaneuroblastomasusceptibilitygenethatregulatestranscriptionfactorsofthenoradrenergiccellidentity